Global Paediatric Vaccine Industry on Track for a 13.1% CAGR, Reaching US$184.7 Billion by 2033 | FMI

The Global Paediatric Vaccine Industry is poised for unprecedented growth, with a current valuation of US$54,130.1 million in 2023. Forecasts indicate a remarkable Compound Annual Growth Rate (CAGR) of 13.1%, propelling the market to a staggering US$184,706.7 million by 2033. This substantial expansion underscores the increasing importance and demand for paediatric vaccines worldwide. The burgeoning …

Global Paediatric Vaccine Industry Set to Soar to a $184.7 Billion Valuation by 2033 at a CAGR of 13.1% | FMI

In 2023, the Global Paediatric Vaccine Industry is valued at US$ 54,130.1 million, with a projected extraordinary Compound Annual Growth Rate (CAGR) of 13.1%. This robust growth trajectory is anticipated to propel the market to a substantial valuation of US$ 184,706.7 million by 2033, underscoring the imminent and substantial expansion of the paediatric vaccine market …

Paediatric Vaccine Industry on Track to Reach US$ 184.7 Billion, at a CAGR of 13.1% Through 2033 | FMI Insights

The Paediatric Vaccine Industry is poised for significant growth in the coming years, with a projected CAGR of 13.1% from 2023 to 2033, according to a new report by Future Market Insights (FMI). The market valuation is expected to reach US$ 184.7 billion by 2033, up from US$ 54.1 billion in 2023. Get Full PDF …

US-Backed Innovations Set the Stage for North American Pediatric Vaccines Industry 2023 To 2033 | FMI Findings

In a significant development, the United States continues to assert its leadership in the North American Pediatric Vaccines Industry, maintaining a substantial market share of 17.9% throughout 2022. This milestone is underpinned by a robust enhancement of healthcare facilities across the country, opening up new avenues for the efficient distribution of pediatric vaccines. Simultaneously, there …